Radicle Health 25: A Study of Health and Wellness Products on Overall Health

Launched by RADICLE SCIENCE · Jun 18, 2025

Keywords

ClinConnect Summary

This clinical trial is studying how certain health and wellness products might improve overall health. The study is designed so that neither the participants nor the researchers know who is receiving the real product or a placebo (a “fake” product) until the study is over. This helps ensure the results are fair and accurate. The trial is not yet recruiting participants but will include adults aged 21 and older who live in the United States and are interested in trying these products without knowing exactly what they are until the end.

To be eligible, participants need to be at least 21 years old, able to read and understand English, and willing to use the study product as directed. People who are pregnant, breastfeeding, have certain serious health problems, take specific medications, or don’t have reliable internet access won’t be able to join. Participants can expect to take the product at home and provide information about their health during the study. This trial aims to see if these wellness products can help improve health in a meaningful way for everyday adults.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Adults, at least 21 years of age at the time of electronic consent, inclusive of all ethnicities, races, and gender identities
• • Assigned sex at birth will determine sex-specific recruitment and surveys (male vs female) employed, when needed
• • Resides in the United States
• • Has the opportunity for at least 30% improvement in their primary health outcome
• • Expresses a willingness to take a study product and not know the product identity (active or placebo) until the end of the study
• Exclusion Criteria:
• • Report being pregnant, trying to become pregnant, or breastfeeding
• • Unable to provide a valid US shipping address and mobile phone number
• • Reports current enrollment in another clinical trial
• • Reports being a heavy drinker (defined as drinking 3 or more alcoholic beverages per day)
• • Unable to read and understand English
• • Reports a current and/or recent (up to 3 months ago) major illness and/or surgery that poses a known, significant safety risk.
• • Reports a diagnosis of cardiac dysfunction, liver or kidney disease that presents a known contraindication and/or a significant safety risk with any of the study product ingredients.
• • NYHA Class III or IV congestive heart failure, atrial fibrillation, uncontrolled arrhythmias, cirrhosis, end-stage liver disease, stage 3b or 4 chronic kidney disease, or kidney failure
• • Reports taking medications that have a well-established moderate or severe interaction, posing a substantial safety risk with any of the study product ingredients.
• • Anticoagulants, antihypertensives, anxiolytics, antidepressants, chemotherapy, immunotherapy, sedative hypnotics, seizure medications, medications that warn against grapefruit consumption, corticosteroids at doses greater than 5 mg per day, diabetic medications, oral anti-infectives (antibiotics, antifungals, antivirals) to treat an acute infection, antipsychotics, MAOIs, or thyroid products
• • Reports current use of the primary ingredient(s) and/or similar product(s) to the active study product(s) that may limit the effects of the study products
• • Lack of reliable daily access to the internet